Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C21H29N5O3 |
| Molecular Weight | 399.4867 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COCCN(CCOC)C1=NC(C)=NC2=C(C(C)=NN12)C3=CC=C(OC)C=C3C
InChI
InChIKey=DKAPUZDMFUBEBM-UHFFFAOYSA-N
InChI=1S/C21H29N5O3/c1-14-13-17(29-6)7-8-18(14)19-15(2)24-26-20(19)22-16(3)23-21(26)25(9-11-27-4)10-12-28-5/h7-8,13H,9-12H2,1-6H3
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Discovery of N-(1-ethylpropyl)-[3-methoxy-5-(2-methoxy-4-trifluoromethoxyphenyl)-6-methyl-pyrazin-2-yl]amine 59 (NGD 98-2): an orally active corticotropin releasing factor-1 (CRF-1) receptor antagonist. | 2011-06-23 |
|
| Degradation pathways of a corticotropin-releasing factor antagonist in solution and solid states. | 2009-08 |
Patents
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
7FC996ZZL5
Created by
admin on Tue Apr 01 16:40:10 GMT 2025 , Edited by admin on Tue Apr 01 16:40:10 GMT 2025
|
PRIMARY | |||
|
202578-88-9
Created by
admin on Tue Apr 01 16:40:10 GMT 2025 , Edited by admin on Tue Apr 01 16:40:10 GMT 2025
|
PRIMARY | |||
|
9908904
Created by
admin on Tue Apr 01 16:40:10 GMT 2025 , Edited by admin on Tue Apr 01 16:40:10 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)